Leukemia: Blood Cancer Symptoms, Types, and Treatment

Leukemia is a complex blood cancer that affects the bone marrow and blood cells, accounting for approximately 3.3% of all new cancer cases in the United States in 20251 . Although it is the most common cancer in children and teens, leukemia occurs more frequently in older adults, with the highest diagnosis rates among those aged 65 to 74 years1 . Advances in diagnosis and treatment have improved survival rates, with a five-year relative survival of about 68% overall, varying by leukemia subtype1 .

Leukemia Types

Leukemia is classified based on the speed of disease progression and the type of blood cell affected2 . The two main categories are acute and chronic leukemias. Acute leukemias progress rapidly and involve immature blood cells called blasts, which multiply quickly and impair normal blood cell function3 . Chronic leukemias develop more slowly and involve more mature blood cells that may function normally for some time3 .

Leukemia also arises from two primary blood cell lineages: lymphoid and myeloid4 . Myeloid cells are progenitors that differentiate into granulocytes, monocytes, erythrocytes (red blood cells), and platelets5 . Lymphoid cells develop into various types of lymphocytes, which are part of the immune system.

The major types of leukemia include:

Acute lymphoblastic leukemia (ALL): The most common leukemia in children, characterized by rapid growth of immature lymphoid cells6 .
Acute myeloid leukemia (AML): The most common acute leukemia in adults but can also occur in children; involves myeloid blasts5 .
Chronic lymphocytic leukemia (CLL): The most prevalent leukemia in adults, especially older individuals; often progresses slowly7 .
Chronic myeloid leukemia (CML): Typically diagnosed in adults with a median age of 64 years; involves mature myeloid cells and may have a prolonged asymptomatic phase5 .
Chronic myelomonocytic leukemia (CMML): A rare leukemia mostly seen in older adults7 .

The clinical course and treatment depend on the leukemia subtype, cell lineage, and disease tempo2 . The World Health Organization (WHO) classification incorporates immunophenotyping, cytogenetics, and molecular genetics to aid diagnosis and risk stratification4 .

Leukemia Symptoms and Signs

Symptoms of leukemia are often non-specific and can resemble other common illnesses, making early diagnosis challenging8 . The presentation varies by leukemia subtype, but general symptoms are common across types9 .

Common signs and symptoms include:

Fatigue, weakness, and lethargy due to anemia from impaired red blood cell production9 10.
Fever and frequent infections caused by leukopenia (low white blood cell count) 910.
Easy bruising, bleeding gums, petechiae (tiny red or purple spots on the skin), and mucosal bleeding due to thrombocytopenia (low platelet count) 911.
Pallor, reflecting anemia, is a frequent early sign10 .
Swollen lymph nodes, enlarged liver or spleen, and bone pain may also occur9 .
Oral manifestations such as gingival bleeding and petechiae can be early indicators11 .
Skin lesions and sores may be present in some cases11 .

Because symptoms are often vague and of low risk, many leukemia diagnoses are unexpected findings during routine blood tests or evaluations for other conditions8 .

Leukemia Causes and Risk Factors

Leukemia results from the uncontrolled proliferation of abnormal blood cells in the bone marrow, disrupting normal hematopoiesis (blood cell formation) 3. The etiology is multifactorial, involving genetic mutations and environmental exposures6 .

Risk Factors

Ionizing radiation: Exposure to radiation is a well-established risk factor for leukemia12 .
Occupational exposure to chemicals: Benzene and other industrial chemicals increase leukemia risk12 .
Genetic predisposition: Family history and inherited genetic syndromes such as Down syndrome, Fanconi anemia, and ataxia-telangiectasia elevate the risk, especially for ALL6 .
Age: Leukemia incidence increases with age, particularly for AML and CLL5 .
Ethnicity: In the United States, leukemia incidence is higher among Whites compared to Blacks12 .
Previous cancer treatment: Chemotherapy and radiation for other cancers can lead to secondary leukemias, though the benefits of such treatments outweigh the risks12 .
Viral infections: Human T-cell leukemia virus type 1 (HTLV-1) is linked to adult T-cell leukemia/lymphoma, and Epstein-Barr virus (EBV) is associated with Burkitt lymphoma12 .

Most individuals with leukemia have no identifiable risk factors, and many with risk factors do not develop the disease6 .

Diagnosing Leukemia

Diagnosis begins with clinical evaluation and laboratory tests. A complete blood count (CBC) often reveals abnormal blood cell counts suggestive of leukemia4 .

Key diagnostic steps include:

Physical examination: Checking for lymphadenopathy (swollen lymph nodes), hepatosplenomegaly (enlarged liver or spleen), and petechiae9 .
Medical history: Assessing symptoms, risk factors, and family history9 .
Blood tests: CBC and peripheral blood smear to detect abnormal cells and assess blood cell morphology4 .
Bone marrow aspiration and biopsy: Essential for definitive diagnosis, determining the percentage of leukemic cells, and classifying leukemia subtype4 .
Genetic and molecular testing: Cytogenetic analysis and molecular assays identify chromosomal abnormalities and mutations that guide prognosis and treatment2 4.
Additional tests: Lumbar puncture to check for central nervous system involvement and imaging studies if organ infiltration is suspected4 13.

Accurate classification using these methods is critical for personalized treatment planning.

Leukemia Treatment Options

Treatment strategies depend on leukemia type, genetic profile, patient age, and overall health2 . The main treatment modalities include chemotherapy, stem cell transplantation, targeted therapy, and radiation therapy.

Chemotherapy

Chemotherapy remains the cornerstone of leukemia treatment, particularly for acute leukemias3 . It involves multiple phases:

Induction therapy: Aims to achieve remission by rapidly reducing leukemic cells. For AML, induction typically lasts about 7 days; for ALL, around 4 weeks3 .
Consolidation therapy: Follows remission to eliminate residual disease. Duration varies by subtype, generally 3–4 months for AML and 1–2 months for ALL3 .
Maintenance therapy: Used mainly in ALL to prevent relapse, lasting 1–2 years3 .

Traditional chemotherapy regimens include anthracyclines and cytarabine2 . Treatment intensity and duration are tailored based on patient factors and leukemia genetics2 .

Stem Cell Transplant

Stem cell transplantation (also called bone marrow transplant) involves high-dose chemotherapy and/or radiation to eradicate leukemia cells, followed by infusion of healthy stem cells to restore normal blood cell production3 . It is considered for:

Patients with high-risk or refractory disease.
Those who relapse after chemotherapy.
Certain leukemia subtypes with poor prognosis3 .

Stem cell sources include bone marrow, peripheral blood, and umbilical cord blood14 . Transplantation carries risks but can offer potential cure or long-term remission.

Targeted Therapy

Targeted therapies are designed to inhibit specific genetic mutations or pathways driving leukemia2 . For example, tyrosine kinase inhibitors (TKIs) are effective in treating chronic myeloid leukemia by targeting the BCR-ABL fusion protein2 15. Personalized treatment based on genetic profiling improves outcomes and reduces toxicity2 .

Radiation Therapy

Radiation therapy is less commonly used but may be applied in certain cases, such as:

Preparing patients for stem cell transplantation.
Treating localized leukemic infiltration.
Managing central nervous system involvement13 .

Radiation is often combined with other treatments to improve efficacy.

Leukemia Prevention Strategies

Currently, there are no proven strategies to prevent leukemia due to its complex and multifactorial etiology involving genetic and environmental factors6 . Most cases occur in individuals without identifiable risk factors6 .

However, minimizing known risk exposures may reduce risk:

Avoid unnecessary exposure to ionizing radiation12 .
Limit occupational exposure to benzene and harmful chemicals12 .
Avoid smoking, which increases risk of AML12 .
Use chemotherapy and radiation judiciously in cancer treatment, balancing benefits and risks12 .

Ongoing research aims to better understand leukemia causes and identify potential preventive measures.

Living With Leukemia Diagnosis

A leukemia diagnosis profoundly impacts patients and their families emotionally, psychologically, and financially7 . The disease and its treatment often require prolonged medical care and support7 .

Key aspects of living with leukemia include:

Coping with emotional distress through psychosocial support and mental health services7 .
Accessing financial assistance and practical support to manage treatment costs7 .
Building a strong social support network involving family, friends, and support groups7 .
Maintaining hope and motivation, as many patients achieve remission and improved quality of life16 .